Objective: To evaluate data addressing use of anticoagulation in elderly patients with atrial fibrillation (AF), in particular those at risk of falls. Data Sources: Primary literature was ...

A new study from the University of Bath has found that for older adults with atrial fibrillation (AF), stopping blood ...

They also base their decisions to stop anticoagulants on past experiences with people who took the anticoagulant warfarin, Mitchell said. Up until 2012, warfarin was the only option to treat Afib.

Opens in a new tab or window For patients with HIV and atrial fibrillation, this study found that apixaban was associated with less bleeding when compared with warfarin and rivaroxaban.

Atrial Fibrillation (Afib) is a common, yet serious heart condition that requires proper diagnosis and management strategies.

A new study suggests that the benefits of prescribing anticoagulation drugs to certain older people outweigh the potential risks. For patients with atrial fibrillation, the risk of stroke or heart ...

A risk-assessment tool incorporating NT-proBNP and high-sensitivity troponin performs better than clinical scores for ...

The results showed that patients taking diltiazem had a 20% higher risk of being hospitalized or dying due to serious ...

Atrial fibrillation (AF) is the most common cardiac arrhythmia, and its incidence increases with age. Current data suggest that anticoagulation with warfarin or dabigatran is far superior to ...

For patients with atrial fibrillation, the risk of stroke or heart attack from stopping anticoagulants usually outweighs the risk of bleeding, according to new findings from the University of Bath.

Persistent atrial fibrillation (AFib) has long been a challenging cardiac condition to treat. Affecting millions worldwide, its complexities often stump healthcare providers in delivering effective ...